PEPTIDE CORTEXThe library
← The library

GHRP-2

researchGH Axis
Evidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeGH axis
MechanismGrowth hormone secretagogue
EffectsSignals the GH axis; can affect body composition, fluid retention, and glucose
DosingNo human dose established.
Bottom linePopular in research/compounding; human safety/benefit not well-established.
Protocols · as published1 sourced
Community protocol — not clinically establishedVendor guide
RouteSubcutaneous
Frequency2-3x daily
StartingNot separately specified
EscalationNone described
Target"100 mcg per injection, 2 to 3 times per day" (200-300 mcg/day)

At least 90 min fasted before, 30 min fasting after. The only approval anywhere is a single diagnostic IV dose in Japan; no therapeutic human dose exists.

Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Not FDA-approved; endocrine risks

Can raise glucose; monitor if on diabetes meds; fluid retention may affect BP/CHF; avoid with active malignancy (per clinical guidance).

CV 1 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.